Uber and its rival Lyft were both at DPharm Disruptive Innovation US to pitch themselves as the answer to an enduring inefficiency in clinical trials.
Antidote, the tech startup formerly known as TrialReach, is gearing up to introduce a tool to automatically match patients’ EHRs to clinical trials.
AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.
Tute Genomics is crowdfunding a DNA sequencing scheme. The campaign is aiming to raise $100,000 by offering whole genome sequencing for between $999 and $1,499.
Medidata has signed up to provide its cloud platform and mobile health capabilities to Techfields Pharma.
Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.
Apple has bought three-year-old startup Gliimpse to build out its health data capabilities.
The team that founded Firecrest Clinical and led it to a takeout by CRO Icon has raised $6 million for its next startup, teckro.
TrialReach has named former Google Ventures Europe partner Eze Vidra as its chief innovation officer.
Medisafe has started pitching an app and services to increase medication adherence and facilitate patient recruitment to biopharma companies.